Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-2.57M.
ENTERPRISE VALUE (EV)
$-2.57M
Metagenomi, Inc. Common Stock
Market Cap
$39.15M
Enterprise Value (EV)
$-2.57M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Metagenomi, Inc. Common Stock (MGX) | $39.15M | $-2.57M |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.77M | $76.47M |
| Veru Inc. (VERU)vs › | $39.80M | $18.61M |
| Nephros, Inc. (NEPH)vs › | $37.94M | $34.11M |
| Incannex Healthcare Limited (IXHL)vs › | $37.81M | N/A |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.64M | N/A |
| QT Imaging Holdings, Inc. (QTI)vs › | $37.45M | $30.81M |
| Precipio, Inc. (PRPO)vs › | $41.86M | $42.12M |
| Edesa Biotech, Inc. (EDSA)vs › | $36.41M | $26.08M |
| EUDA Health Holdings Limited (EUDA)vs › | $36.04M | $38.10M |
Market Cap
$39.15M
Total Debt
$0.00
Cash
$41.72M
Enterprise Value
$-2.57M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
